Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Peter Clark, MA, MD, FRCP: A Payer Perspective

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Oct
07
Today In Oncology
The Molecular Watchman Why Measurable Residual Disease Testing Is Redefining Treatment and Surveillance in Colorectal and Bladder Cancers
Tile-Based Radiation Outperforms Postoperative Stereotactic Radiation Therapy in Resected Brain Metastases
Replacing Intensive Chemotherapy With Blinatumomab Improves Outcomes in High-Risk Pediatric Acute Lymphoblastic Leukemia
Pediatric and Adolescent Colorectal Carcinoma: A Retrospective Analysis
Autonomous AI Triaged Urgent Suspected Skin Cancer Referrals in Real-World Implementation Study
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo